Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • WUXI PHARMATECH CAYMAN INC Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2008 FY2007 FY2006 FY2005 FY
    Assets
    Cash and Short Term Investments 72.59 M 219.11 M 183.10 M 5.49 M —
    Net Receivables 36.46 M 18.20 M 12.73 M 4.85 M —
    Total Inventories 6.93 M 13.35 M 9.62 M 3.39 M —
    Progress Payments & Others 0.00 0.00 0.00 0.00 —
    Prepaid Expenses 5.21 M 1.82 M 306,210.91 — —
    Other Current Assets 13.79 M 6.00 M 734,073.01 477,003.86 —
    Current Assets Total 129.77 M 261.88 M 208.01 M 14.51 M —
    Long Term Receivables 0.00 0.00 0.00 0.00 —
    Investment in Unconsolidated Subsidiaries 0.00 0.00 0.00 0.00 —
    Other Investments 0.00 0.00 359,636.01 247,125.93 —
    Property, Plant & Equipment Net 152.70 M 73.64 M 42.78 M 25.06 M —
    Property, Plant & Equipment Gross 183.15 M 88.84 M 49.53 M 28.20 M —
    Accumulated Depreciation 30.44 M 15.20 M 6.76 M 3.14 M —
    Other Assets 45.12 M 7.80 M 5.27 M 586,014.83 —
    Deferred Charges 5.42 M 0.00 4.64 M 0.00 —
    Tangible Other Assets 5.81 M 1.72 M 0.00 0.00 —
    Intangible Other Assets 33.89 M 6.08 M 628,442.01 586,014.83 —
    Total Assets 327.59 M 343.31 M 256.41 M 40.40 M —
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 7.56 M 0.00 9.60 M 9.70 M —
    Accrued Payroll — — — — —
    Income Taxes Payable 708,307.28 4.06 M 64,582.00 359,651.89 —
    Dividends Payable 742,112.78 — — — —
    Other Current Liabilities 30.71 M 34.29 M 6.56 M 5.96 M —
    Current Liabilities Total 58.80 M 45.57 M 25.49 M 18.45 M —
    Long Term Debt 38.17 M 45.09 M 46.40 M 5.04 M —
    Provision for Risks & Charges — — — — —
    Deferred Taxes -8.81 M -282,020.06 -503,597.01 -337,304.90 —
    Deferred Income — — — — —
    Deferred Tax Liability in Untaxed Reserves — — — — —
    Other Liabilities 6.73 M 0.00 1.03 M 0.00 —
    Total Liabilities 94.90 M 90.38 M 72.41 M 23.16 M —
    Shareholders Equity
    Non-Equity Reserves 1.82 M 1.53 M — — —
    Minority Interest 0.00 0.00 0.00 0.00 —
    Preferred Stock 0.00 0.00 0.00 0.00 —
    Common Equity 230.88 M 251.40 M 184.00 M 17.24 M —
    Common Stock 10.59 M 9.84 M 9.90 M — —
    Capital Surplus 324.63 M 291.02 M 257.60 M — —
    Revaluation Reserves 0.00 0.00 — — —
    Other Appropriated Reserves 0.00 7.84 M — — —
    Unappropriated (Free) Reserves — — — — —
    Retained Earnings -121.51 M -57.30 M -85.20 M — —
    Equity in Untaxed Reserves — — — — —
    ESOP Guarantees 0.00 0.00 — — —
    Unrealized Foreign Exchange Gain (Loss) 17.16 M 7.84 M 2.10 M — —
    Unrealized Gain (Loss) on Marketable Securities 0.00 0.00 — — —
    Treasury Stock 0.00 0.00 400,000.01 — —
    Total Liabilities & Shareholders Equity 327.59 M 343.31 M 256.41 M 40.40 M —
    Common Shares Outstanding 66.17 M — — — —